kp 1 pengantar blok 2.4 hematolimfopoietik.ppt

Upload: hasramukhlisan

Post on 14-Apr-2018

260 views

Category:

Documents


2 download

TRANSCRIPT

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    1/41

    HEMATOLIMFOPOIETIKBLOK 11

    FAKULTAS KEDOKTERAN

    UNIVERSITAS ANDALAS

    PADANG

    2008/2009

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    2/41

    Tim Pengelola Blok 11

    KORDINATOR 1 : Dr Irza Wahid SpPD KHOM

    WAKIL KORDINATOR : Prof DR Dr H Ellyza Nasrul SpPK (K)

    Staf bidang materi : - Prof Dr H Nusirwan Acang DTM&H SpPD KHOM- Dr H Firman Arbi SpA (K)

    Staf bidang Skill / Psikomotor : - Prof Dr Hanifah Maani SpPK (K)

    - Dr Tuti Prihandani SpPK

    Staf Bidang Monitoring / Evaluasi / Administrasi

    - Dr Efrida SpPK M Kes

    - Dr Zelly Dia Rofinda SpPK

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    3/41

    Nama : Dr Irza Wahid SpPD KHOM

    Tempat / Tanggal Lahir : Padang / 23 November 1967

    Alamat : Jalan Kolam Indah Raya No A6 Cendana Mata Air Padang

    Telp. : 07516195208126605439

    Pekerjaan : Staf Subagian HematologiOnkologi MedikBagian Ilmu Penyakit dalam FK Unand / RS Dr M Djamil

    RIWAYAT PENDIDIKAN

    No

    Nama Pendidikan Nama Sekolah Waktu

    1 SD SD Yos Sudarso Padang 1973 -1980

    2 SMP SMP Negeri 1 Padang 1980 -1983

    3 SMA SMA Negeri 1 Padang 1983 -1986

    4 Kedokteran Umum FK Unand Padang 1986 1993

    5 Program Pendidikan Dokter

    Spesialis I Ilmu Penyakit Dalam

    FK Unand / BLU RS Dr M Djamil

    Padang

    01/07/1998 10/07/ 2003

    6 Program Awal Pendidikan Dokter

    Spesialis II Konsultan Hematologi

    Onkologi Medik

    FK Unand / BLU RS Dr M Djamil

    Padang

    FKUI / RSCM / RSKD Jakarta

    01/01/2004 31/12/2006

    7 Program S3 Biomedik FK Unand FK Unand 01/07/2008 sekarang

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    4/41

    Modul 1 : anemia defisiensi dan aplastik.

    Modul 2 : anemia hemolitik dan pasca perdarahan.

    Modul 3 : gangguan hemostasis.

    Modul 4 : leukemia.

    Modul 5 : limfadenopati.

    Modul 6 : transfusi darah.

    Skills labs : Uji Rumple Leed

    : Flebotomi

    Praktikum : Hematologi

    : Patologi Anatomi

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    5/41

    TOPIK PRAKTIKUM BLOK XI

    Minggu I. Anemia

    Evaluasi darah tepi dan sumsum tulang

    1.Anemia defisiensi Fe

    2.Anemia aplasi

    3.Anemia hemolitik

    Minggu II. Hitung eritrosit dan retikulosit

    Minggu III. Bleeding Time (cara Ivy), Retraksi bekuan dan

    Golongan Darah

    Minggu IV. Evaluasi darah tepi dan SST : ALL (L1-L3) dan CLLMinggu V. Evaluasi darah tepi dan SST : AML (M1-M7) dan

    LGK

    Minggu VI. Limfadenopati (PA)

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    6/41

    Hematopoeitik :Sum-sum tulang --------------------------------> Darah tepi

    Pluripotent stem cell

    I. Myeloid progenitor cellA.Erythro-MKprogenitor cellEritropoesiseritrosit Anemia / PolisitemiaMegakariopoesistrombosit Trombositosis / Trombositopenia

    B.Gran-monoprogeni tor cellGranulopoesis leukosit Leukopenia / LeukositosisMonositopoesis monosit Monositopenia / Monositosis

    II. Lymphoid progenitor cellLimfopoesislimfosit Limfositopenia / Limfositosis

    sel plasma

    Extramedular ------------------------------------> Hati / Limpa

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    7/41

    ANEMIA Parameter : Kadar hemoglobin Metode Sahli

    Pria dewasa : Wanita dewasa : Hamil : Hb < 13 : < 12 : < 11 gr %

    Gejala dan tanda

    Hb hipoksia kompensasi kardiovaskular

    * Pucat * angina pektoris * kardiomegali

    Mukosa * claudicatio intermiten * palpitasi

    Kulit * tinitus * dispneu

    * berkunang * bising sistolik

    * cepat lelah * gagal jantung Gradasianemia ringan : sedang : berat : > 8 : 6 8 : < 6 gr %

    Morfologi mikro / normo / makrositer -- hipo/normo/hiperkrom

    Patofisiologi defisiensi aplastik hemolitik perdarahan

    Etiologi Cacing, low intake, kelainan imun, trauma

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    8/41

    LEUKEMIADefinisi : Proliferasi abnormal dari dari sel induk darah

    Serial Mieloid Serial LimpoidLeukemia mieloblastik akut Leukemia limfoblastik akut( Tu. Dewasa muda ) ( Tu. Anak-anak )

    Leukemia mielositik kronik Leukemia limfositik kronik

    ( dewasa muda + orang tua ) ( Semua umur )

    Etiologi : Unknown Virus, radiasiGejala klinis : - Anemia

    - Infeksi

    - Trombositopenia

    - Hiperkatabolikhiperurisemia- Infiltrasi organorganomegali, hipertrofi gusi,

    meningeal, cerebral

    Diagnosis : Hapusan darah tepi blast > 5 %BMP blast > 30 % / > 20 % (WHO, 2001)Sitokimia, immunophenotype, sitogenetik

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    9/41

    HEMOSTASIS - DIATESIS HEMORAGIS

    - TROMBOSIS

    Vaskular

    Trombosit Koagulasi

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    10/41

    Non HodgkinHodgkin

    Proliferation

    andTransformation Proliferation

    Specific

    Non neoplasm / Infection

    Non specific

    LimfomaSecondary /metatstatic

    MalignantBenign

    Neoplasm

    Lymphadenopathy

    LIMFADENOPATI

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    11/41

    TRANSFUSI DARAH

    * ERITROSIT PRC, WE, DFRC

    *LEUKOSIT

    * TROMBOSIT

    * PLASMAKRIOPRESIPITAT KONSENTRAT Fc VIII

    KRIOSUPERNATAN ALBUMIN, IMUNOGLOBULIN

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    12/41

    REAKSI TRANSFUSI

    Definisi :Komplikasi / efek samping yang terjadi akibat

    pemberian transfusi

    Klasifikasi

    Imunologi : Produksi anti bodi terhadap

    aloantigen pada eritrosit, leukosit,

    trombosit atau protein plasma darah Non Imunologik : Berhubungan dengan bahan

    fisika/kimia komponen darah atau

    kontaminan

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    13/41

    DAFTAR PUSTAKA

    - Greer, Foerster, Lukeni, et al.Wintrobes Clinical Hematology 2thedition, 2004.

    - Devita VT, Hellman S, Rosenberg SA, et al. Cancer Principles &

    Practice of Oncology 7th edition , 2005

    - Colman RW, Marder VJ, Clowes AW, et al.Hemostasis &

    Thrombosis Basic Principles & Clinical Practice, 2006

    - Sudoyo AW, Setiyohadi B, Idrus A et al. Buku Ajar Ilmu Penyakit

    Dalam Jilid 2 Edisi 4 , 2006.

    - Waldo E, Nelson RE, Robert K et al. Nelson Text Book of

    pediatrics, 17 th edition, 2004.-Permono B, Sutaryo,Ugrasena IDG et al. Buku Ajar Hematologi

    Onkologi Anak, 2005.

    - Ganda Subrata, Penuntun Laboratorium Klinik

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    14/41

    Factors necessary for

    erythropoiesis

    1. Erythropoietin

    2. Iron

    3. Vitamin B12 (cyanocobalamin) 4. Folic Acid (folate)

    5. Ascorbic acid (Vitamin C)

    6. Pyridoxine (Vitamin B6) 7. Amino acids

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    15/41

    Deficient RBC Production

    Neoplasia: covered by another lecturer

    Myelofibrosis: Remove spleen; transfusion whennecessary with packed cells.

    Pernicious anemia: B12 injections Microcytic (iron deficiency) anemia: iron: only

    ferrous iron (sulfate, fumarate, gluconate). Ferric ironis not absorbedliquid Geritol wont do.

    Aplastic anemia: stop medication; may have to dobone marrow transplant

    Renal disease: Correct if possible, otherwise renaltransplant

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    16/41

    Normoblasts

    Pronormoblast

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    17/41

    Regulation of Erythropoiesis

    Normal body requirements for oxygen is 250

    ml/min

    Almost all of that is for use in oxidative

    phosphorylation by the mitochondria.

    The heart normally pumps out 1,000 ml

    oxygen per minute.

    Less than 250 ml/min causes tissue hypoxia

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    18/41

    Regulation of Erythropoiesis

    Kidneys receive 25% of cardiac outputapproximately 1,250 ml of blood/minyetit is only 0.5% of body weight.

    The 1,250 ml/min contains 250 ml/min ofoxygen

    The amount of oxygen/min received by thekidneys is the same as that required by body

    tissues/min. Therefore, renal monitoring of oxygen is

    logical choice.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    19/41

    Regulation of Erythropoiesis

    If renal tissue is hypoxic, erythropoietin isproduced by renal peritubular interstitial cells.

    The gene for erythropoietin is located on

    chromosome 7. Erythropoietin is not the only factor required

    for red cell development. We will cover some

    of these later.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    20/41

    Regulation of Erythropoiesis

    While the kidney produces most of theerythropoietin, the liver and other tissues alsoproduce some.

    In fetal life, the liver produced all of theerythropoietinas the final kidneythe

    metanephros - had not yet completeddevelopment.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    21/41

    Regulation of Erythropoiesis

    Erythropoietin increases RBC production in 3

    ways:

    Promotes pronormoblast production

    Shortens the transition time through the

    normoblast stage

    Promotes the early release of reticulocytes.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    22/41

    Regulation of Erythropoiesis

    How many are produced: 25 billion /24 hours.

    The entering cells are reticulocytes which

    should be 1% of the total population ofcirculating erythrocytes.

    Erythrocytes last 120 days and are destroyed by

    the spleen.

    Red cell production should equal red cell

    destruction.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    23/41

    Determination of RBC size

    MCV = mean corpuscular volume in femtoliters(10-15 liters) abbreviated fl.

    This is the most accurate method of measuring redblood cells and is the one done by automatedCoulter counters.

    MCH = mean corpuscular hemoglobin does notadd anything to the diagnosis except additionalexpense. It will not be considered further.

    eren a agnos s us ng

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    24/41

    eren a agnos s us ngMCV

    Macrocytic anemias (MCV = 150 fl)larger than normal cells

    Normocytic (MCV = 80-96 fl)cells arenormal in volume.

    Microcytic anemias (MCV = 50 fl)cells

    are smaller than normal.

    ur scuss on o anem a s

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    25/41

    ur scuss on o anem a slimited to:

    We will only discuss those anemias that are due toa deficiency of:

    Iron

    Folic acid Vitamin B12

    Vitamin

    Or those anemias that will be benefitted by theadministration of erythropoietin.

    .

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    26/41

    Iron Iron deficiency is the most common cause ofanemia.

    Results in microcytic hypochromic anemia.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    27/41

    Iron is used in: Hemoglobin. Heme enzymes, e.g., cytochromes, catalase,

    peroxidase

    Myoglobin Metalloflavoprotein enzymes such as xanthine

    oxidase

    The mitochondrial enzyme alpha-glycerophosphate

    oxidase and other mitochondrial enzymes.

    Other enzymes and processes

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    28/41

    Iron in hemoglobin

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    29/41

    Iron in hemoglobin

    Iron Deficiency Common

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    30/41

    Iron Deficiency

    Common

    Causes

    Inadequate dietary intake of iron especiallyin:

    Infants in the postnatal period

    Young females after menarche Adolescents of both sexes

    During pregnancy

    Iron Deficiency Common

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    31/41

    Iron Deficiency

    Common

    Causes (cont)

    Partial gastrectomy due to ulcers Blood loss due to:

    Bleeding peptic ulcers

    Malignancy Trauma in which there is excessive bleeding

    (includes blood loss through extensive bruising)

    Malabsorption syndromes

    Cystic fibrosis

    Celiac Disease (nontropical sprue)

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    32/41

    Iron Deficiencylead toxicity

    Can lead to lead toxicity from pica Iron deficiency enhances uptake of heavy

    metals, including lead.

    Lead is still used in all outside house paint.

    Lead is highly concentrated in the first fewinches of soil in citiesfrom car exhaust of 20years or more ago.

    Infants love to each picatheir taste of the world.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    33/41

    Heme iron and nonheme iron

    Heme iron very well absorbed. Present inmuscle as part of myoglobin.

    But: Do not eat meat that is bloody.Bacteria love blood and it can be the source

    of severe food poisoning.

    Nonheme iron not absorbed well but forms

    the bulk of dietary iron.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    34/41

    IronAbsorption

    Absorbed from the duodenum (where most

    drugs are absorbed) and upper jejunum.

    Vitamin C taken with the iron increases

    absorption by reducing dietary ferric to ferrous

    iron.

    Caffeine and other xanthines decrease

    absorption.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    35/41

    IronPreparations available

    Only absorbed well in the ferrous(us is forus) form. Ferrous sulphate, ferrous gluconateand ferrous fumarate are three that are

    available. Ferric form only 10% absorbedick! Ferric

    ammonium citrate is in Geritol Tonic.

    However, patients feel goodcould it bebecause of the 12% alcohol content?

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    36/41

    IronNot from Geritol Tonic

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    37/41

    Iron TherapySide effects of

    oral preparations Nausea

    Gastric discomfort

    Constipation

    Diarrhea

    Good idea to start patients on small doses and

    increase gradually. Less side effects that way.

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    38/41

    IronParenteral solution Should be used cautiously because 0.2% to

    3% of patients develop hypersensitivityincluding anaphylactic shock to parenteraliron.

    Parenteral iron does not appear to provide afaster response than oral preparations.

    Only one in Saskatchewan: iron dextran

    Reasons for use:

    Renal failure

    Short bowel

    Celiac disease (sprue)

    ANEMIA DEFISIENSI

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    39/41

    ANEMIA DEFISIENSIBESI

    Metabolisme Besi

    Intake( Fe 3+ = Ferri )( daging organ, kacang polong, air tebu, daun sup, kerang )

    Fe 3+ Fe 2+ = Ferro

    Mukosa duodenum / jejunum prox ( Absorbs i)

    Fe 2 + Fe 3+

    Transferin ( Transport)

    Mioglobin / enzim Hemoglobin(Jaringan) (Eritrosit)

    Feritin / hemosiderin ( Storage)

    ( Sistim RE )

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    40/41

    EtiologiAsupan Kehi langan Fe Kebutuhan meningkat

    - malnutrisi - perdarahan - hamil / laktasi- ggn absorbsi - GGK / HD - anak-anak

    Patofisiologi

    - Def Fe prelaten / deplesi Fe

    cad. Fe ,Fe serum dbn- Def Fe laten cad. Fe habis, Hb batas bwh N- Anemia Def Fe

    Gejala Klinis- gejala anemia

    - gejala defisiensi atrofi papil lidah, stomatitis angularis,disfagia, koilonychia

    - gejala penyakit dasar

  • 7/29/2019 KP 1 Pengantar Blok 2.4 Hematolimfopoietik.ppt

    41/41

    DIAGNOSIS* Anemia, retikulosit menurun

    * Mikrositer, hipokrom, anulosit

    * SI menurun / TIBC meningkat* Transferin < 16 mg %

    * Feritin serum < 12 mg %

    * SST : Hiperplasia eritropoetik, pengecatan besi ( - )

    * Pemeriksaan untuk mencari penyebab

    PENATALAKSANAAN* Preparat besi 3 X 200 mgHb normal maintenance 3 X 100 mg (3 bln)

    * Pengobatan penyakit dasar